Column Group

About Column Group

The Column Group (TCG) is a venture ecosystem focused on fueling scientific innovation in the life sciences and biotechnology sectors. It supports early-stage biotech companies and single-asset therapeutics through a multi-fund model, helping navigate from inception through exit. With a history spanning over two decades, TCG emphasizes hands-on collaboration with portfolio companies and leadership to advance therapies and technology platforms across the life sciences landscape. The firm operates in the biotech and healthcare investment space, partnering with founders and researchers to accelerate clinical development and commercialization.